Filing Details

Accession Number:
0001209191-17-007630
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-03 16:35:20
Reporting Period:
2017-02-01
Filing Date:
2017-02-03
Accepted Time:
2017-02-03 16:35:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661567 Michael Parini 50 Northern Avenue
Boston MA 02210
Evp, Clo & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-01 3,450 $85.98 10,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1.